{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:24Z","timestamp":1787169864660,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:p>Systemic amyloidosis is a rare disease characterized by clinical polymorphism. Indeed, the kidney is the most common organ involved and represents a real turning point in the disease. We aimed to determine the clinicopathological prognostic factors of renal amyloidosis (RA). We conducted a retrospective study including 40 cases with biopsy-proven RA collected in our department over a period of 10 years. Biochemical, demographic, and clinicopathological findings at diagnosis, as well as the follow-up data, were evaluated for each patient. The prevalence of amyloidosis was 2.7 per 100 nontransplant renal biopsies. The mean age at presentation was 55.5 \u00b1 15.6 years with a male-to-female ratio of 1.85. The diagnosis of RA was confirmed by a renal biopsy in 85% of cases. Amyloid A (AA) amyloidosis was the most common type of amyloidosis (65%), and chronic infections ranked first in the panel of etiologies (41%). Amyloid light chain amyloidosis was mainly associated with multiple myeloma (57%). The median patient survival was 59 months versus 12 months for kidney survival. Age and extrarenal localization were independent predictors of mortality, whereas renal failure at presentation significantly influenced renal survival. The results of our study emphasize the rarity but also the severity of RA. AA amyloidosis was the most common type identified, which was mainly caused by chronic infections. Prevention remains the best solution until we can achieve therapeutic advances in inflammatory diseases.<\/jats:p>","DOI":"10.4103\/1319-2442.385967","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:11:55Z","timestamp":1695003115000},"page":"432-439","source":"Crossref","is-referenced-by-count":1,"title":["The Clinical Features and Outcomes of Renal Amyloidosis in Tunisia"],"prefix":"10.4103","volume":"33","author":[{"given":"Amel","family":"Ayed","sequence":"first","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem Ben","family":"Salem","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Letaief","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel Ben","family":"Salah","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insaf","family":"Handous","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Hamouda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabra","family":"Aloui","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Skhiri","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Kidney Transplantation, Fattouma Bourguiba University Hospital, Monastir, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00709-020-01513-0","article-title":"Renal amyloidosis: An update on diagnosis and pathogenesis","volume":"257","author":"Gupta","year":"2020","journal-title":"Protoplasma"},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"R3-20230928","doi-asserted-by":"crossref","DOI":"10.1177\/2374289519888731","article-title":"Educational case: Dysproteinemic nephropathies: Renal amyloi-dosis as an example","volume":"6","author":"Jebakumar","year":"2019","journal-title":"Acad Pathol"},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12882-019-1601-x","article-title":"Pattern of renal amyloidosis in South Africa","volume":"20","author":"Hassen","year":"2019","journal-title":"BMC Nephrol"},{"key":"R6-20230928","first-page":"37","article-title":"Review of eprodisate for the treatment of renal disease in AA amyloidosis","volume":"5","author":"Rumjon","year":"2012","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s10157-016-1326-0","article-title":"A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: A cross-sectional study","volume":"21","author":"Nishi","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4103\/1319-2442.243966","article-title":"Clinical and laboratory profile of renal amyloidosis: A single-center experience","volume":"29","author":"Engineer","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R9-20230928","first-page":"79","article-title":"Renal amyloidoses in nephrology","volume":"34","author":"Koumou","year":"2019","journal-title":"Pan Afr Med J"},{"key":"R10-20230928","first-page":"7","article-title":"Epidemiological, clinical and laboratorial profile of renal amyloidosis: A 12-year retros-pective study of 37 cases","volume":"4","author":"da Fonseca","year":"2015","journal-title":"J Nephropathol"},{"key":"R11-20230928","article-title":"Profil \u00c9pid\u00e9miologique, Clinique et \u00c9volutif des Amyloses R\u00e9nales Diagnostiqu\u00e9es au CHU Sahloul Sur Une P\u00e9riode de 10 Ans","author":"Boukadida","year":"2018","journal-title":"Th D M\u00e9d Sousse"},{"key":"R12-20230928","first-page":"A100","article-title":"Profil \u00e9tiologique de l'amylose r\u00e9nale: \u00c9tude de 635 cas","volume":"36S","author":"Kaaroud","year":"2015","journal-title":"Rev M\u00e9d Interne"},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1097\/HS9.0000000000000454","article-title":"Systemic AL amyloidosis: Current approaches to diagnosis and management","volume":"4","author":"Fotiou","year":"2020","journal-title":"Hemasphere"},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.currproblcancer.2016.08.002","article-title":"Renal amyloidosis","volume":"40","author":"Kidd","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nephro.2015.06.007","article-title":"Pathological and clinical correlations in renal AA amyloidosis: A Moroccan series of 30 cases","volume":"11","author":"Bziz","year":"2015","journal-title":"Nephrol Ther"},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"e8625","DOI":"10.1590\/1414-431x20208625","article-title":"Correlation between amyloid deposits affecting renal compartments and glomerular filtration rate during renal biopsy in a renal amyloidosis case series","volume":"53","author":"Fonseca","year":"2020","journal-title":"Braz J Med Biol Res"},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nephro.2017.03.001","article-title":"AA amyloidosis","volume":"13","author":"Stojanovic","year":"2017","journal-title":"Nephrol Ther"},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"e13966","DOI":"10.1111\/ijcp.13966","article-title":"Infections and AA amyloidosis: An overview","volume":"75","author":"Deshayes","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaip.2020.09.023","article-title":"AA amyloidosis secondary to primary immune deficiency: About 40 cases including 2 new French cases and a systematic literature review","volume":"9","author":"Delplanque","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R20-20230928","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.rbr.2016.12.002","article-title":"Clinical outcomes and survival in AA amyloidosis patients","volume":"57","author":"Ayar","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10157-016-1271-y","article-title":"Long-term prognosis of AL and AA renal amyloidosis: A Japanese single-center experience","volume":"21","author":"Ozawa","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ndt\/gfm684","article-title":"Renal involvement in systemic amyloidosis: An Italian collaborative study on survival and renal outcome","volume":"23","author":"Bergesio","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R23-20230928","article-title":"Amylose R\u00e9nale \u00e0 Propos de 127 Cas","author":"Hammadi","year":"2007","journal-title":"Th D M\u00e9d Monastir"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.385967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:15Z","timestamp":1787166855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.385967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/1319-2442.385967","relation":{},"ISSN":["1319-2442","2320-3838"],"issn-type":[{"value":"1319-2442","type":"print"},{"value":"2320-3838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}